<div>
  <ul>
    <li>
      <p>
        Cortica, a telepsychiatry platform specializing in autism spectrum disorders, has raised an additional USD 40 million in a Series D extension, bringing the total Series D funding round to USD 115 million. CVS Health Ventures led the round, along with LRVHealth, Ascension Investment Management, and the University of Wisconsin Foundation, among other investors.
      </p>
    </li>
    <li>
      <p>
        The additional funding will support the nationwide expansion of Cortica's autism care model and investments in technology, data capture, research, and enhancement of the clinician and patient experience. 
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.prnewswire.com/news-releases/cortica-closes-40-million-series-d-extension-led-by-cvs-health-ventures-lrvhealth-and-other-strategic-investors-bringing-round-total-to-115-million-301946200.html">
      Press release
    </a>
  </p>
  <p>
    <a href="https://bhbusiness.com/2023/10/03/cvs-health-venture-leads-40m-series-d-extension-for-all-in-one-autism-therapy-provider-cortica/">
      Behavioural Health Business
    </a>
  </p>
  <p>
    <a href="https://www.finsmes.com/2023/10/cortica-closes-40m-series-d-extension.html">
      FinSMEs
    </a>
  </p>
  <p>
  </p>
</div>


Mental Health Tech

Telepsychiatry platform Cortica has raised an extra $40 million in a Series D extension, taking the total funding round to $115 million. The funding was led by CVS Health Ventures, alongside other investors including LRVHealth, Ascension Investment Management, and the University of Wisconsin Foundation. The money will be used to expand Cortica's autism care model nationwide, as well as invest in technology, data capture, research, and improving the experience for clinicians and patients.

All Updates

Cortica closes USD 40 million Series D extension

Cortica raises USD 75 million in Series D funding

Cortica Inc receives investment from the Autism Impact Fund